Moderna, Inc.
MRNAUS売上高
$1.9B
百万USD
営業利益
$-3.1B
百万USD
純利益
$-2.8B
百万USD
ROE
-32.6%
最新FY
EPS
$-7.26
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | - | $1.2B | $2.84 |
| FY2021 | Q2 | - | $2.8B | $6.46 |
| FY2021 | Q3 | - | $3.3B | $7.70 |
| FY2021 | FY | - | $12.2B | $28.29 |
| FY2022 | Q1 | - | $3.7B | $8.58 |
| FY2022 | Q2 | - | $2.2B | $5.24 |
| FY2022 | Q3 | - | $1.0B | $2.53 |
| FY2022 | FY | - | $8.4B | $20.12 |
| FY2023 | Q1 | - | $79M | $0.19 |
| FY2023 | Q2 | - | $-1.4B | $-3.62 |
| FY2023 | Q3 | $1.8B | $-3.6B | $-9.53 |
| FY2023 | FY | $6.8B | $-4.7B | $-12.33 |
| FY2024 | Q1 | $167M | $-1.2B | $-3.07 |
| FY2024 | Q2 | $241M | $-1.3B | $-3.33 |
| FY2024 | Q3 | $1.9B | $13M | $0.03 |
| FY2024 | FY | $3.2B | $-3.6B | $-9.28 |
| FY2025 | Q1 | $108M | $-971M | $-2.52 |
| FY2025 | Q2 | $142M | $-825M | $-2.13 |
| FY2025 | Q3 | $1.0B | $-200M | $-0.51 |
| FY2025 | FY | $1.9B | $-2.8B | $-7.26 |
| FY2026 | Q1 | $389M | $-1.3B | $-3.40 |
財務データ
| 指標 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| 売上高 | - | $60M | - | - | - | $6.8B | $3.2B | $1.9B |
| 営業利益 | $-413M | $-546M | $-763M | $13.3B | $9.4B | $-4.2B | $-3.9B | $-3.1B |
| 純利益 | $-385M | $-514M | $-747M | $12.2B | $8.4B | $-4.7B | $-3.6B | $-2.8B |
| 総資産 | $2.0B | $1.6B | $7.3B | $24.7B | $25.9B | $18.4B | $14.1B | $12.3B |
| 純資産 | - | - | - | - | - | - | - | - |
| 自己資本 | $1.5B | $1.2B | $2.6B | $14.1B | $19.1B | $13.9B | $10.9B | $8.7B |
| 営業CF | $-331M | $-459M | $2.0B | $13.6B | $5.0B | $-3.1B | $-3.0B | $-1.9B |
| EPS | - | - | - | $28.29 | $20.12 | $-12.33 | $-9.28 | $-7.26 |
| BPS | $4.65 | $3.19 | $6.41 | $35.11 | $49.50 | $36.26 | $28.25 | $21.90 |
| ROE | -25.1% | -43.8% | -29.2% | 86.3% | 43.7% | -34.0% | -32.7% | -32.6% |